Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 61F. Hoffmann-La Roche

02 3Genentech

03 2ORIFARM GROUP AS

04 1Roche Products (Pty) Ltd

05 8Roche Diagnostics GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Solution for injection

Dosage Strength : 1,875 mg

Packaging : Vials 1 15ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date : 21/09/2017

Application Number : 20160430000118

Regulatory Info : Approved

Registration Country : Sweden

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Injectable Solution

Dosage Strength : 1875mg

Packaging :

Approval Date : 18/01/2024

Application Number : 20221116000072

Regulatory Info : Approved

Registration Country : Sweden

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date : 26/08/2019

Application Number : 20180914000090

Regulatory Info : Approved

Registration Country : Sweden

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg/14ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : TECENTRIQ subcutaneous

Dosage Form : Injectable Solution

Dosage Strength : 1875mg/15ml

Packaging :

Approval Date : 05/08/2024

Application Number : 69262

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1200MG/20ML

Packaging :

Approval Date :

Application Number : 761034

Regulatory Info :

Registration Country : USA

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 1200MG/20ML

Packaging :

Approval Date :

Application Number : 761041

Regulatory Info :

Registration Country : USA

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ATEZOLIZUMAB AND HYALURONIDASE-TQJS

Brand Name : TECENTRIQ HYBREZA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 125MG;2000UNITS PER ML

Packaging :

Approval Date :

Application Number : 761347

Regulatory Info :

Registration Country : USA

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 840MG

Packaging :

Approval Date : 2024-07-15

Application Number : 1171220002IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

16

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 1200MG

Packaging :

Approval Date : 2021-05-10

Application Number : 1171220001IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

17

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 840MG

Packaging :

Approval Date : 2021-01-08

Application Number : 1171220002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

18

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 1200MG

Packaging :

Approval Date : 2024-07-15

Application Number : 1171220001IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

19

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 840MG

Packaging :

Approval Date : 2019-10-15

Application Number : 1171220002

Regulatory Info : Authorized

Registration Country : Spain

blank

20

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 1200MG

Packaging :

Approval Date : 2017-10-17

Application Number : 1171220001

Regulatory Info : Authorized

Registration Country : Spain

blank